About Us


Welcome to Beta Drugs Ltd(Adley Group), a pioneering force in the oncology medicine industry. Founded in 1985 by the visionary Late Shri Vijay Batra. Its stands as a beacon of hope in the realm of oncology drug manufacturers. The company has evolved a lot under the dynamic leadership of Mr. Rahul Batra, Managing Director, and Mr. Varun Batra, Joint Managing Director.

The leading oncology medicine manufacturing company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. Our journey began with the unwavering dedication of our founder and has evolved into a testament to our expertise in oncology pharmaceuticals. With an extensive presence encompassing over 80% of corporate and governmental institutions across India, we have emerged as a trusted name in the pharmaceutical landscape. We cater to the needs of over 50 leading Indian pharmaceutical companies, ensuring that patients have access to cutting-edge treatments and therapies. With a presence in over 46 nations, we have demonstrated our ability to deliver innovative solutions that transcend borders.

We relentlessly focus on research and development to continuously strive to innovate and elevate the standards of cancer care. With a rich legacy of excellence and a forward-thinking approach, we are dedicated to shaping a future where every individual battling cancer can access the care they deserve.

Our Promises

Extending care to manage disease better

We have a dedicated team of scientists who are extensively working for product development that is not only help to treat disease but also provide better patient compliance like dose flexibility, easier administration, high safety & efficacy.

Addressing unmet patient need

Side effects from anticancer medicines are very common in cancer patients & negatively affect to survival, morbidity & Quality of Life

We have a comprehensive supportive care portfolio to address such unmet needs.

Disseminate Knowledge

We have been an ardent facilitator of patient care initiatives and disseminating scientific updates to the medical fraternity.

Bringing expensive medicine within reach

We develop our in-house API and formulations. It helps us to reduce the cost of expensive medicine.

This accelerated access to low-cost generic cancer medicine to the patients.

Copyright 2024. All right reserved